Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Anthrocell

Anthrocell
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of a novel technological platform designed for the development, production and manufacture of next generation pharmaceuticals. The company's anthrocell platform and biobetters provides monoclonal antibody products for oncology applications and produces biopharmaceutical proteins, enabling patients to get cured from cancer and age-related diseases.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Post Office Box 1268
  • Maroubra, New South Wales 2035
  • Australia

+61 (02) 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Anthrocell’s full profile, request a free trial.

Anthrocell Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Anthrocell Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Cicada Innovations Accelerator/Incubator Minority 000 0000 000000 0

Anthrocell Executive Team (3)

Name Title Board
Seat
Contact
Info
Galina Kaseko Co-Founder, Chief Executive Officer & Board Member
Tohsak Mahaworasilpa Co-Founder, Chief Scientific Officer & Board Member
Eli Tal Executive Chairman

Anthrocell Board Members (3)

Name Representing Role Since Contact
Info
Eli Tal Anthrocell Executive Chairman 000 0000
Nicholas Weininger Anthrocell Board Member 000 0000
Tohsak Mahaworasilpa Anthrocell Co-Founder, Chief Scientific Officer & Board Member 000 0000